DOI: https://dx.doi.org/10.18565/pharmateca.2018.5.16-25

A.V. Tarantsova

City outpatient clinic № 10, Rostov-on-Don, Regional Health Center, Rostov-on-Don, Russia
The article presents the main chronological milestones, the mechanism of action and the spectrum of pharmacological effects of reference and generic ethylmethylhydroxypyridine succinate-based preparations, the regulatory and legal framework, a review of the effectiveness of clinical use from the perspective of evidence-based medicine and personal author’s experience of their use in practically healthy young people (examined in the Health Center) and elderly patients with comorbid cardiological and neurological disorders.

About the Autors

Corresponding author: A.V. Tarantsova – PhD, doctor of the highest qualification categoryat the Regional Health Center, City Outpatient Clinic №10, physiotherapist, Rostov-on-Don, Russia; e-mail: alexandrina-2015@mail.ru, ORCID: https://orcid.org/0000-0003-1447-1973

Similar Articles

Бионика Медиа